NO310854B1 - Anvendelse av mometasonfuroat og salisylsyre for fremstilling av et farmasoytisk preparat, samt et farmasoytisk preparat inneholdende disse - Google Patents

Anvendelse av mometasonfuroat og salisylsyre for fremstilling av et farmasoytisk preparat, samt et farmasoytisk preparat inneholdende disse Download PDF

Info

Publication number
NO310854B1
NO310854B1 NO19962619A NO962619A NO310854B1 NO 310854 B1 NO310854 B1 NO 310854B1 NO 19962619 A NO19962619 A NO 19962619A NO 962619 A NO962619 A NO 962619A NO 310854 B1 NO310854 B1 NO 310854B1
Authority
NO
Norway
Prior art keywords
mometasone furoate
salicylic acid
ointment
psoriasis
pharmaceutical composition
Prior art date
Application number
NO19962619A
Other languages
English (en)
Norwegian (no)
Other versions
NO962619L (no
NO962619D0 (no
Inventor
Edwin A Peets
Daniel J Tanner
Eugene L Taylor
Joel A Sequeira
Imtiaz A Chaudry
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO962619L publication Critical patent/NO962619L/no
Publication of NO962619D0 publication Critical patent/NO962619D0/no
Publication of NO310854B1 publication Critical patent/NO310854B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19962619A 1993-12-21 1996-06-20 Anvendelse av mometasonfuroat og salisylsyre for fremstilling av et farmasoytisk preparat, samt et farmasoytisk preparat inneholdende disse NO310854B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17105193A 1993-12-21 1993-12-21
PCT/US1994/014165 WO1995017196A1 (en) 1993-12-21 1994-12-19 Psoriasis treatment

Publications (3)

Publication Number Publication Date
NO962619L NO962619L (no) 1996-06-20
NO962619D0 NO962619D0 (no) 1996-06-20
NO310854B1 true NO310854B1 (no) 2001-09-10

Family

ID=22622295

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19962619A NO310854B1 (no) 1993-12-21 1996-06-20 Anvendelse av mometasonfuroat og salisylsyre for fremstilling av et farmasoytisk preparat, samt et farmasoytisk preparat inneholdende disse

Country Status (21)

Country Link
EP (1) EP0735885B1 (cs)
JP (2) JP3830963B2 (cs)
KR (1) KR100361240B1 (cs)
CN (1) CN1055392C (cs)
AT (1) ATE271896T1 (cs)
AU (1) AU701833B2 (cs)
CA (1) CA2179628C (cs)
CZ (1) CZ283932B6 (cs)
DE (1) DE69433923T2 (cs)
ES (1) ES2221928T3 (cs)
FI (1) FI117001B (cs)
HU (1) HU226621B1 (cs)
IL (1) IL112019A (cs)
MY (1) MY111719A (cs)
NO (1) NO310854B1 (cs)
NZ (1) NZ278198A (cs)
PL (1) PL178427B1 (cs)
SK (1) SK280766B6 (cs)
TW (1) TW442281B (cs)
WO (1) WO1995017196A1 (cs)
ZA (1) ZA9410143B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19736265C2 (de) * 1997-08-15 2002-10-31 Phytexpert Pharm Tox Consultin Arzneimittel zur Behandlung von Hauterkrankungen
JP4101464B2 (ja) * 1998-08-26 2008-06-18 塩野義製薬株式会社 抗炎症軟膏剤
GR1006093B (el) * 2007-09-07 2008-10-06 Γεωργιος Καλλιμανης Παρασκευη φαρμακου με δραστικο συστατικο ουρσολικο οξυ (ursolic acid) για την θεραπεια ψωριασης
NZ591093A (en) * 2008-10-30 2012-02-24 Ego Pharmaceuticals Pty Ltd Anti-inflammatory pharmaceutical compositions comprising a corticosteroid, hexylene glycol and water
EP2394653A1 (en) 2010-05-26 2011-12-14 Almirall, S.A. Topical pharmaceutical compositions comprising mometasone furoate
CN114159453A (zh) * 2021-12-24 2022-03-11 广西馨海药业科技有限公司 白头翁皂苷b4在制备治疗或预防银屑病的药物的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4579844A (en) * 1976-05-13 1986-04-01 Johnson & Johnson Topical anti-inflammatory drug therapy
DE2744826A1 (de) * 1976-10-06 1978-04-13 Marques Brev Soc Et Exploit Therapeutische zubereitung
CY1359A (en) * 1981-02-02 1987-08-07 Schering Corp Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
YU46838B (sh) * 1986-02-14 1994-06-24 Pero Dr. Višnjić Postupak za dobijanje preparata za lečenje kožne bolesti psoriazisa
US4808610A (en) * 1986-10-02 1989-02-28 Schering Corporation Mometasone furoate anti-inflammatory cream composition using hexylene glycol
US4775529A (en) * 1987-05-21 1988-10-04 Schering Corporation Steroid lotion
US5061700A (en) * 1989-11-16 1991-10-29 Gordon Jay Dow Glyceryl acetate ointment vehicles

Also Published As

Publication number Publication date
NO962619L (no) 1996-06-20
JP3830963B2 (ja) 2006-10-11
AU1432895A (en) 1995-07-10
EP0735885B1 (en) 2004-07-28
DE69433923T2 (de) 2005-07-21
HU9601708D0 (en) 1996-08-28
PL315150A1 (en) 1996-10-14
MY111719A (en) 2000-11-30
ES2221928T3 (es) 2005-01-16
NO962619D0 (no) 1996-06-20
FI962506L (fi) 1996-06-17
WO1995017196A1 (en) 1995-06-29
CN1055392C (zh) 2000-08-16
CN1138294A (zh) 1996-12-18
HUT74460A (en) 1996-12-30
CZ178496A3 (en) 1997-04-16
SK280766B6 (sk) 2000-07-11
ATE271896T1 (de) 2004-08-15
JPH09506897A (ja) 1997-07-08
HU226621B1 (en) 2009-04-28
FI117001B (fi) 2006-05-15
TW442281B (en) 2001-06-23
FI962506A0 (fi) 1996-06-17
HK1008814A1 (en) 1999-05-21
CA2179628A1 (en) 1995-06-29
JP2005139210A (ja) 2005-06-02
KR100361240B1 (ko) 2003-01-29
CA2179628C (en) 2000-10-24
IL112019A (en) 2000-02-17
KR960706345A (ko) 1996-12-09
AU701833B2 (en) 1999-02-04
CZ283932B6 (cs) 1998-07-15
IL112019A0 (en) 1995-03-15
NZ278198A (en) 1997-12-19
EP0735885A1 (en) 1996-10-09
SK81896A3 (en) 1997-04-09
DE69433923D1 (de) 2004-09-02
ZA9410143B (en) 1995-06-20
PL178427B1 (pl) 2000-04-28

Similar Documents

Publication Publication Date Title
Fredriksson et al. Urea creams in the treatment of dry skin and hand dermatitis.
US6096326A (en) Skin care compositions and use
KR20050089740A (ko) 주사 치료를 위한 국소적 제형
Stein et al. Betamethasone valerate foam for treatment of nonscalp psoriasis
EP1867322B1 (en) Topical composition for the treatment of psoriasis
JP2015530380A (ja) 乾癬を治療するための組成物
Li et al. Dermatological pharmacology: topical agents
NO310854B1 (no) Anvendelse av mometasonfuroat og salisylsyre for fremstilling av et farmasoytisk preparat, samt et farmasoytisk preparat inneholdende disse
AU2024227116A1 (en) An anhydrous pharmaceutical composition for maintenance treatment of psoriasis
Marinho et al. Clinical efficacy and safety profile of topical etofenamate in the treatment of patients with musculoskeletal disorders: a systematic review
JPH03227921A (ja) ケロイド治療剤
JPH06199672A (ja) 活性成分としてクロラムフェニコール、ゲンタマイシンおよびナイスタチンを含有する、炎症性皮膚疾患の局所治療のための配合製剤
EP2934520B1 (en) Use of pidotimod to treat atopic dermatitis
JPS62155214A (ja) 炎症治療薬及びそれによる炎症治療方法
HK1008814B (en) Ointments comprising mometasone furoate and salicylic acid for the topical treatment of psoriasis
Winkle Clinical feature: Eczema and psoria: Atopic dermatitis (eczema) or psoriasis: how to tell the difference
Shenenberger Curbing the psoriasis cascade: Therapies to minimize flares and frustration
Bhatia et al. ATIN Ps0RIASIS: AN UPDATE
Chaplin et al. Xamiol: betamethasone plus calcipotriol for scalp psoriasis

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: MERCK SHARP AND DOHME CORP

Free format text: NEW ADDRESS: 126 EAST LINCOLN AVENUE, US-NJ07065 RAHWAY, US

MK1K Patent expired